{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:28:12Z","timestamp":1792931292504,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpharm.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T07:45:18Z","timestamp":1488872718000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Enhanced non invasive trans -tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies"],"prefix":"10.1016","volume":"522","author":[{"given":"Abdulaziz Mohsen","family":"Al-mahallawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omneya Mohammed","family":"Khowessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raguia Ali","family":"Shoukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.03.005_bib0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10837450903479988","article-title":"Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes","volume":"16","author":"Abdelbary","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2011.10.043","article-title":"Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro\/in vivo evaluation","volume":"422","author":"Aburahma","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2014.06.041","article-title":"Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment","volume":"472","author":"Al-Mahallawi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhazmat.2007.05.061","article-title":"Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida","volume":"151","author":"Annadurai","year":"2008","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2010.03.034","article-title":"Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications","volume":"393","author":"Araujo","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-5173(00)00362-8","article-title":"The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether","volume":"201","author":"Arunothayanun","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","article-title":"SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization","volume":"391","author":"Basalious","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08982104.2013.788025","article-title":"Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole","volume":"23","author":"Basha","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2014.04.030","article-title":"Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation","volume":"468","author":"Bendas","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0055","series-title":"Otitis Media in Infants and Children","author":"Bluestone","year":"2007"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0005-2736(91)90335-6","article-title":"Polymorphism of the bilayer membranes in the ordered phase and the molecular origin of the lipid pretransition and rippled lamellae","volume":"1062","author":"Cevc","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0065","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.procbio.2003.11.002","article-title":"Application of statistical experimental design for optimization of alkaline protease production from Bacillus sp. RGR-14","volume":"39","author":"Chauhan","year":"2004","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/17425247.5.7.737","article-title":"Colloidal carriers for the enhanced delivery through the skin","volume":"5","author":"Cosco","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cej.2010.11.062","article-title":"Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design","volume":"166","author":"de Lima","year":"2011","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0080","first-page":"939","volume":"47","author":"Ding","year":"2002"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0085","first-page":"283","article-title":"Development and characterization of nanoparticles of glibenclamide by solvent displacement method","volume":"67","author":"Dora","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0090","doi-asserted-by":"crossref","first-page":"418316","DOI":"10.1155\/2011\/418316","article-title":"Characterization and In vitro skin permeation of meloxicam-loaded liposomes versus transfersomes","volume":"2011","author":"Duangjit","year":"2011","journal-title":"J. Drug Delivery"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5173(99)00441-X","article-title":"Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration","volume":"196","author":"El Maghraby","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archotol.1990.01870050057006","article-title":"Topical and oral treatment of chronic otitis media with ciprofloxacin: a preliminary study","volume":"116","author":"Esposito","year":"1990","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0110","first-page":"411","article-title":"Antibiotic ear drop use in the nonintact tympanic membrane","volume":"13","author":"Fairbanks","year":"1984","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(00)00669-4","article-title":"In vitro skin permeation of estradiol from various proniosome formulations","volume":"215","author":"Fang","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2004.12.022","article-title":"Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study","volume":"293","author":"Gupta","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1211\/0022357055515","article-title":"Tetanus toxoid-loaded transfersomes for topical immunization","volume":"57","author":"Gupta","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","article-title":"Spanlastics\u2013a novel nanovesicular carrier system for ocular delivery","volume":"413","author":"Kakkar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/10837450.2012.685655","article-title":"A novel nanovesicular carrier system to deliver drug topically","volume":"18","author":"Kakkar","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcatb.2006.02.019","article-title":"Statistical optimization of medium components and growth conditions by response surface methodology to enhance lipase production by Aspergillus carneus","volume":"40","author":"Kaushik","year":"2006","journal-title":"J. Mol. Catal. B: Enzym."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0145","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.biomaterials.2012.10.025","article-title":"Formulations for trans-tympanic antibiotic delivery","volume":"34","author":"Khoo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0150","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/lary.21088","article-title":"Comparison of systemic and otic administration of ofloxacin","volume":"120","author":"Koulich","year":"2010","journal-title":"Laryngoscope"},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2017.03.005_bib0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000239312","article-title":"Controlled prospective study of oral ciprofloxacin versus amoxycillin\/clavulanic acid in chronic suppurative otitis media in adults","volume":"40","author":"Legent","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0160","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/0024-3205(80)90268-4","article-title":"Liposomes\u2013a selective drug delivery system for the topical route of administration. Lotion dosage form","volume":"26","author":"Mezei","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0165","series-title":"Clarke's Analysis of Drugs and Poisons","first-page":"1111","article-title":"Monographs: ciprofloxacin","author":"Moffat","year":"2011"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0170","first-page":"64","article-title":"Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles","volume":"20","author":"Moore","year":"1996","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0175","series-title":"Niosomal Drug Delivery for Transdermal Targeting: Recent Advances","author":"Muzzalupo","year":"2015"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/10717544.2014.889779","article-title":"Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits","volume":"22","author":"Nour","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2012.05.010","article-title":"Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route","volume":"100","author":"Salama","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982104.2013.801489","article-title":"Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization","volume":"23","author":"Shamma","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-199958002-00007","article-title":"Toxicity of quinolones","volume":"58","author":"Stahlmann","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0205","first-page":"151","article-title":"Acute otitis media-a structured approach","volume":"111","author":"Thomas","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0001-8686(95)00242-I","article-title":"Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry","volume":"58","author":"Uchegbu","year":"1995","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(01)00576-2","article-title":"Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements","volume":"217","author":"van den Bergh","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/INF.0b013e31818b0c9c","article-title":"Ciprofloxacin 0.3%\/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature","volume":"28","author":"Wall","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0225","first-page":"2147","article-title":"Acute otitis media","volume":"53","author":"Worrall","year":"2007","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0005-2736(96)00167-8","article-title":"Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines","volume":"1285","author":"Zeisig","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.03.005_bib0235","doi-asserted-by":"crossref","first-page":"e87711","DOI":"10.1371\/journal.pone.0087711","article-title":"Systematic review of evidence-based guidelines on medication therapy for upper respiratory tract infection in children with AGREE instrument","volume":"9","author":"Zeng","year":"2014","journal-title":"PLoS One"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:52:46Z","timestamp":1535989966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317301722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0378517317301722"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.005","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}